AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 31332998 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual immunotherapy for 6 months
Number of subjects: 48
Study 31332998 — intervention group
Group type: COMPARATOR
Intervention: Omega-3 fatty acids for 3 months
Number of subjects: 48
Study 27233583 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized meal
Number of subjects: 0
Study 27233583 — intervention group
Group type: COMPARATOR
Intervention: Moxifloxacin
Number of subjects: 0
Study 25878177 — intervention group
Group type: EXPERIMENTAL
Intervention: Perampanel 8 mg
Number of subjects: 0
Study 25878177 — intervention group
Group type: EXPERIMENTAL
Intervention: Perampanel 12 mg
Number of subjects: 0
Study 25878177 — intervention group
Group type: EXPERIMENTAL
Intervention: Perampanel 2 mg
Number of subjects: 0
Study 25878177 — intervention group
Group type: EXPERIMENTAL
Intervention: Perampanel 4 mg
Number of subjects: 0
Study 25878177 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 25878177 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-EIAEDs
Number of subjects: 0
Study 25878177 — intervention group
Group type: EXPERIMENTAL
Intervention: EIAEDs
Number of subjects: 0
Study 23306584 — intervention group
Group type: EXPERIMENTAL
Intervention: Low tidal volume ventilation (approximately 3 ml/kg) combined with extracorporeal CO2 elimination
Number of subjects: 79
Study 23306584 — intervention group
Group type: COMPARATOR
Intervention: ARDSNet strategy (approximately 6 ml/kg) without the extracorporeal device
Number of subjects: 79
Study 22009805 — intervention group
Group type: EXPERIMENTAL
Intervention: Atracourium (5 mg in 0.5 ml)
Number of subjects: 90
Study 22009805 — intervention group
Group type: EXPERIMENTAL
Intervention: cis-Atracourium (5 mg in 0.5 ml)
Number of subjects: 90
Study 22009805 — intervention group
Group type: COMPARATOR
Intervention: Placebo (0.5 ml normal saline)
Number of subjects: 90
Study 20467603 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-mm-long Rescue implants (Megagen)
Number of subjects: 30
Study 20467603 — intervention group
Group type: COMPARATOR
Intervention: 10-mm-long implants placed in augmented bone
Number of subjects: 30
Study 20467603 — intervention group
Group type: COMPARATOR
Intervention: Augmented group (10-mm-long implants)
Number of subjects: 30
Study 20467603 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 30
Study 16914693 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon beta-1b (IFNB-1b) 250 mug subcutaneously every other day (EOD)
Number of subjects: 468
Study 16914693 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 468
Study 16003621 — intervention group
Group type: COMPARATOR
Intervention: Conventional maxillomandibular fixation (MMF)
Number of subjects: 30
Study 16003621 — intervention group
Group type: EXPERIMENTAL
Intervention: Short period of maxillomandibular fixation (MMF) for 2 weeks followed by an arch bar splint wired to the lower jaw
Number of subjects: 30
Study 11862577 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol CR/XL
Number of subjects: 3991
Study 11862577 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3991
Study 10187875 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraparenchymal hemorrhages
Number of subjects: 554
Study 10187875 — intervention group
Group type: EXPERIMENTAL
Intervention: Extraparenchymal bleeding
Number of subjects: 554
Study 10187875 — intervention group
Group type: EXPERIMENTAL
Intervention: Cerebral edema
Number of subjects: 554
Study 10187875 — intervention group
Group type: EXPERIMENTAL
Intervention: Large hematoma with concomitant extraparenchymal bleeding
Number of subjects: 554
Study 10187875 — intervention group
Group type: EXPERIMENTAL
Intervention: Hemorrhagic infarction with cerebral edema
Number of subjects: 554
Study 7709928 — intervention group
Group type: EXPERIMENTAL
Intervention: Osteoporosis therapy (specific intervention details not provided)
Number of subjects: 0
Study 7709928 — intervention group
Group type: COMPARATOR
Intervention: Not applicable (no specific control group mentioned)
Number of subjects: 0
Study 7709928 — intervention group
Group type: COMPARATOR
Intervention: Not applicable (no specific intervention mentioned)
Number of subjects: 0
Study 2311147 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol (2.0‐2.5 mg.kg‐1 followed by a continuous infusion 0.1‐0.2 mg.kg‐1.min‐1)
Number of subjects: 60
Study 2311147 — intervention group
Group type: COMPARATOR
Intervention: Thiopentone (4.0‐5.0 mg.kg‐1, infusion rate 0.16‐0.32 mg.kg‐1.min‐1)
Number of subjects: 60
Study 6107500 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiotherapy plus levamisole 2.5 mg/kg/day for two consecutive days each week for 48 weeks
Number of subjects: 720
Study 6107500 — intervention group
Group type: COMPARATOR
Intervention: Radiotherapy alone
Number of subjects: 720
Study 6107500 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiotherapy plus levamisole
Number of subjects: 720
Study 30915431 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention based on health belief model (HBM) and collaborative learning techniques
Number of subjects: 311
Study 30915431 — intervention group
Group type: COMPARATOR
Intervention: Comparison group (no specific intervention mentioned)
Number of subjects: 311
Study 27757829 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic soy milk containing Lactobacillus planetarum A7
Number of subjects: 40
Study 27757829 — intervention group
Group type: COMPARATOR
Intervention: Pure soy milk (control)
Number of subjects: 40
Study 26400963 — intervention group
Group type: EXPERIMENTAL
Intervention: Baked beef meal
Number of subjects: 17
Study 26400963 — intervention group
Group type: COMPARATOR
Intervention: Baked herring meal
Number of subjects: 17
Study 26400963 — intervention group
Group type: COMPARATOR
Intervention: Pickled herring meal
Number of subjects: 17
Study 23937012 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 60
Study 23937012 — intervention group
Group type: COMPARATOR
Intervention: Physiological saline (Control)
Number of subjects: 60
Study 22032120 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide nasal spray (64 microg per, 256 microg once daily)
Number of subjects: 30
Study 22032120 — intervention group
Group type: COMPARATOR
Intervention: Saline nasal spray (twice daily)
Number of subjects: 30
Study 22032120 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 30
Study 20069203 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol (40 mg per day)
Number of subjects: 30
Study 20069203 — intervention group
Group type: EXPERIMENTAL
Intervention: Nortriptyline (20 mg per day)
Number of subjects: 30
Study 20069203 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of Propranolol and Nortriptyline (40 mg and 20 mg per day respectively)
Number of subjects: 30
Study 20069203 — intervention group
Group type: COMPARATOR
Intervention: Control (Nortriptyline alone)
Number of subjects: 30
Study 17684553 — intervention group
Group type: EXPERIMENTAL
Intervention: Advice book on LBP (the 'back book')
Number of subjects: 2752
Study 17684553 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 2752
Study 15139978 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluconazole (400 mg weekly)
Number of subjects: 90
Study 15139978 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study 11838927 — intervention group
Group type: EXPERIMENTAL
Intervention: Short duration antibiotic prophylaxis (2 days)
Number of subjects: 178
Study 11838927 — intervention group
Group type: COMPARATOR
Intervention: Long duration antibiotic prophylaxis (7 days)
Number of subjects: 178
Study 9521829 — intervention group
Group type: EXPERIMENTAL
Intervention: Remember responses
Number of subjects: 270
Study 9521829 — intervention group
Group type: EXPERIMENTAL
Intervention: Know responses
Number of subjects: 270
Study 9521829 — intervention group
Group type: EXPERIMENTAL
Intervention: Guess responses
Number of subjects: 270
Study 7922057 — intervention group
Group type: EXPERIMENTAL
Intervention: Helium pneumoperitoneum
Number of subjects: 60
Study 7922057 — intervention group
Group type: COMPARATOR
Intervention: Carbon dioxide pneumoperitoneum
Number of subjects: 60
Study 3383994 — intervention group
Group type: EXPERIMENTAL
Intervention: l-carnitine 20 mg/kg
Number of subjects: 10
Study 3383994 — intervention group
Group type: EXPERIMENTAL
Intervention: l-carnitine 40 mg/kg
Number of subjects: 10
Study 3383994 — intervention group
Group type: EXPERIMENTAL
Intervention: l-carnitine 60 mg/kg
Number of subjects: 10
Study 3383994 — intervention group
Group type: COMPARATOR
Intervention: saline (control)
Number of subjects: 10
Study 3383994 — intervention group
Group type: EXPERIMENTAL
Intervention: l-carnitine infusion
Number of subjects: 10
Study 31542965 — intervention group
Group type: EXPERIMENTAL
Intervention: Visit-to-visit BPV (highest quartile)
Number of subjects: 460
Study 31542965 — intervention group
Group type: EXPERIMENTAL
Intervention: Day-to-day BPV
Number of subjects: 460
Study 29185106 — intervention group
Group type: EXPERIMENTAL
Intervention: Band ligation
Number of subjects: 264
Study 29185106 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 264
Study 29185106 — intervention group
Group type: EXPERIMENTAL
Intervention: Carvedilol
Number of subjects: 264
Study 27654729 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical finasteride 0.5%
Number of subjects: 104
Study 27654729 — intervention group
Group type: COMPARATOR
Intervention: Placebo solution
Number of subjects: 104
Study 24641712 — intervention group
Group type: EXPERIMENTAL
Intervention: Cerebral palsy (no specific intervention mentioned)
Number of subjects: 594
Study 22904030 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended-release memantine
Number of subjects: 676
Study 22904030 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 676
Study 22253996 — intervention group
Group type: EXPERIMENTAL
Intervention: Low glycemic index diet
Number of subjects: 58
Study 22253996 — intervention group
Group type: COMPARATOR
Intervention: High glycemic index diet
Number of subjects: 58
Study 17355732 — intervention group
Group type: EXPERIMENTAL
Intervention: Cilastatin co-administered with cyclosporin A
Number of subjects: 229
Study 16301723 — intervention group
Group type: EXPERIMENTAL
Intervention: First-trimester ultrasound examination; mean duration 8.9 minutes, mean MI 0.73 (range 0.3-1.3), mean TI 0.34 (0.1-1.7).
Number of subjects: 37
Study 16301723 — intervention group
Group type: EXPERIMENTAL
Intervention: Second-trimester ultrasound examination; mean duration 31.8 minutes, mean MI 1.04 (0.5-1.5), mean TI 0.28 (0.1-2.4).
Number of subjects: 37
Study 16301723 — intervention group
Group type: EXPERIMENTAL
Intervention: Third-trimester ultrasound examination; mean duration 16.3 minutes, mean MI 1.06 (0.2-1.5), mean TI 0.32 (0.1-2.4).
Number of subjects: 37
Study 16301723 — intervention group
Group type: EXPERIMENTAL
Intervention: Color Doppler imaging during third-trimester examinations; brief changes in TI observed.
Number of subjects: 37
Study 11996956 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenofibrate (200 mg)
Number of subjects: 79
Study 11996956 — intervention group
Group type: COMPARATOR
Intervention: Pravastatin (20 mg initially, increased to 40 mg if necessary)
Number of subjects: 79
Study 10434236 — intervention group
Group type: EXPERIMENTAL
Intervention: Lornoxicam 16 mg
Number of subjects: 76
Study 10434236 — intervention group
Group type: COMPARATOR
Intervention: Tramadol 100 mg
Number of subjects: 76
Study 10434236 — intervention group
Group type: EXPERIMENTAL
Intervention: Lornoxicam (8 mg tid for 3 days)
Number of subjects: 76
Study 10434236 — intervention group
Group type: COMPARATOR
Intervention: Tramadol (100 mg tid for 3 days)
Number of subjects: 76
Study 10434236 — intervention group
Group type: EXPERIMENTAL
Intervention: Lornoxicam
Number of subjects: 76
Study 7776115 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazepam
Number of subjects: 180
Study 7776115 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 180
Study 7776115 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetaminophen
Number of subjects: 180
Study 7776115 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of diazepam and acetaminophen
Number of subjects: 180
Study 1972011 — intervention group
Group type: EXPERIMENTAL
Intervention: Clenbuterol (40 micrograms)
Number of subjects: 10
Study 1972011 — intervention group
Group type: EXPERIMENTAL
Intervention: Mabuterol (50 micrograms)
Number of subjects: 10
Study 1972011 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenoterol (5 mg)
Number of subjects: 10
Study 1972011 — intervention group
Group type: COMPARATOR
Intervention: Control (no beta-adrenergic agonist)
Number of subjects: 10
Study 112656 — intervention group
Group type: EXPERIMENTAL
Intervention: ketotifen (1 mg twice daily)
Number of subjects: 7
Study 112656 — intervention group
Group type: EXPERIMENTAL
Intervention: disodium cromoglycate (20 mg four times daily)
Number of subjects: 7
Study 27749811 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based module (WBM)
Number of subjects: 233
Study 27749811 — intervention group
Group type: EXPERIMENTAL
Intervention: Read-only website (ROW)
Number of subjects: 233
Study 27749811 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (SOC)
Number of subjects: 233
Study 29499082 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional herbal medicine (THM)
Number of subjects: 364
Study 29499082 — intervention group
Group type: COMPARATOR
Intervention: Transarterial chemoembolization (TACE)
Number of subjects: 364
Study 26601786 — intervention group
Group type: EXPERIMENTAL
Intervention: Distraction
Number of subjects: 101
Study 26601786 — intervention group
Group type: EXPERIMENTAL
Intervention: Reappraisal
Number of subjects: 101
Study 26601786 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 101
Study 23810626 — intervention group
Group type: EXPERIMENTAL
Intervention: Go4it group treatment
Number of subjects: 122
Study 23810626 — intervention group
Group type: COMPARATOR
Intervention: Current regular care (control)
Number of subjects: 122
Study 22842422 — intervention group
Group type: EXPERIMENTAL
Intervention: One-stage reconstruction with a round permanent expander implant (Becker 25)
Number of subjects: 40
Study 22842422 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-stage reconstruction with a crescent-shaped expander (LV 133)
Number of subjects: 40
Study 22842422 — intervention group
Group type: COMPARATOR
Intervention: Quality of life evaluation using the 36-Item Short Form Health Survey
Number of subjects: 40
Study 20085534 — intervention group
Group type: EXPERIMENTAL
Intervention: Olmesartan medoxomil (OM) 20 mg/day for 3 weeks, then up-titrated to OM 40 mg/day for 3 weeks, and subsequently to OM/HCTZ 40/12.5 mg/day or OM/HCTZ 40/25 mg/day as necessary
Number of subjects: 192
Study 20085534 — intervention group
Group type: EXPERIMENTAL
Intervention: Olmesartan medoxomil (OM) + Hydrochlorothiazide (HCTZ)
Number of subjects: 192
Study 17073853 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexpanthenol pastille (200 mg, two pastilles sucked 30 min before operation)
Number of subjects: 180
Study 17073853 — intervention group
Group type: COMPARATOR
Intervention: Benzydamine hydrochloride spray (four puffs, sprayed 30 min before operation and 5 min before anaesthesia induction)
Number of subjects: 180
Study 17073853 — intervention group
Group type: COMPARATOR
Intervention: Distilled water (four puffs, sprayed 30 min before operation)
Number of subjects: 180
Study 15764945 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate loading of two single‐standing titanium screw implants with cortical satellite implants and overdentures
Number of subjects: 20
Study 17805122 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive tension sutures alone
Number of subjects: 60
Study 17805122 — intervention group
Group type: EXPERIMENTAL
Intervention: Drains alone
Number of subjects: 60
Study 17805122 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive tension sutures and drains
Number of subjects: 60
Study 17805122 — intervention group
Group type: COMPARATOR
Intervention: Control (no drains, no progressive tension sutures)
Number of subjects: 60
Study 11053710 — intervention group
Group type: EXPERIMENTAL
Intervention: I-123 MIBG SPECT segmental uptake defects
Number of subjects: 55
Study 11053710 — intervention group
Group type: EXPERIMENTAL
Intervention: Mean areas of reduced LV I-123 MIBG uptake
Number of subjects: 55
Study 11053710 — intervention group
Group type: EXPERIMENTAL
Intervention: Myocardial perfusion defects (reversible, fixed, and paradox)
Number of subjects: 55
Study 11053710 — intervention group
Group type: EXPERIMENTAL
Intervention: Topographic association between perfusion, innervation, and wall motion abnormalities
Number of subjects: 55
Study 8997168 — intervention group
Group type: EXPERIMENTAL
Intervention: IVIG-and-aspirin
Number of subjects: 0
Study 8997168 — intervention group
Group type: COMPARATOR
Intervention: Aspirin-alone
Number of subjects: 0
Study 1637763 — intervention group
Group type: EXPERIMENTAL
Intervention: Chorion Villus Sampling (CVS)
Number of subjects: 160
Study 1637763 — intervention group
Group type: COMPARATOR
Intervention: Amniocentesis
Number of subjects: 160
Study 1637763 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 160
Study 6712863 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketanserin
Number of subjects: 9
Study 6712863 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study 30824398 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance exercises 2 days/week and aerobic exercises 1 day/week for 9 months with isoenergetic supplements containing 0, 10, 20, or 30 g whey protein twice daily
Number of subjects: 152
Study 30824398 — intervention group
Group type: EXPERIMENTAL
Intervention: Increases in lean mass
Number of subjects: 152
Study 29399800 — intervention group
Group type: EXPERIMENTAL
Intervention: Alginos Oral Suspension (sodium alginate 1,000 mg three times daily)
Number of subjects: 80
Study 29399800 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study 29399800 — intervention group
Group type: EXPERIMENTAL
Intervention: Alginos Oral Suspension
Number of subjects: 80
Study 27090863 — intervention group
Group type: EXPERIMENTAL
Intervention: Corifollitropin alfa (150 μg single injection)
Number of subjects: 1390
Study 27090863 — intervention group
Group type: COMPARATOR
Intervention: Recombinant FSH (300 IU daily for 7 days)
Number of subjects: 1390
Study 27090863 — intervention group
Group type: EXPERIMENTAL
Intervention: Corifollitropin alfa and Recombinant FSH
Number of subjects: 1390
Study 25049403 — intervention group
Group type: EXPERIMENTAL
Intervention: 7-week psychosocial intervention focused on improving parenting, strengthening family relationships, and building youth competencies.
Number of subjects: 272
Study 25049403 — intervention group
Group type: COMPARATOR
Intervention: Control condition (not specified).
Number of subjects: 272
Study 23036134 — intervention group
Group type: EXPERIMENTAL
Intervention: Anticholinergic therapy (solifenacin 5 mg initially, possible escalation to 10 mg, switch to trospium XR 60 mg)
Number of subjects: 249
Study 23036134 — intervention group
Group type: EXPERIMENTAL
Intervention: OnabotulinumtoxinA (100 U injection)
Number of subjects: 249
Study 23036134 — intervention group
Group type: EXPERIMENTAL
Intervention: Anticholinergic therapy
Number of subjects: 249
Study 23036134 — intervention group
Group type: EXPERIMENTAL
Intervention: OnabotulinumtoxinA
Number of subjects: 249
Study 21175515 — intervention group
Group type: EXPERIMENTAL
Intervention: Vernakalant
Number of subjects: 290
Study 21175515 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 290
Study 18485759 — intervention group
Group type: EXPERIMENTAL
Intervention: Carotid Angioplasty/Stenting (CAS)
Number of subjects: 3227
Study 18485759 — intervention group
Group type: COMPARATOR
Intervention: Carotid Endarterectomy (CEA)
Number of subjects: 3227
Study 15851366 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunonutrition (enteral formula enriched with glutamine, arginine, and omega-3 fatty acids)
Number of subjects: 40
Study 15851366 — intervention group
Group type: COMPARATOR
Intervention: Standard nutrition (standard enteral formula)
Number of subjects: 40
Study 15851366 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunonutrition
Number of subjects: 40
Study 14616431 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular administration of dexmedetomidine (2 microg x kg-1)
Number of subjects: 12
Study 14616431 — intervention group
Group type: EXPERIMENTAL
Intervention: Buccal administration of dexmedetomidine (2 microg x kg-1)
Number of subjects: 12
Study 14616431 — intervention group
Group type: EXPERIMENTAL
Intervention: Peroral administration of dexmedetomidine (2 microg x kg-1)
Number of subjects: 12
Study 10842420 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.47 g protein/kg body cell mass/d (marginal diet)
Number of subjects: 12
Study 10842420 — intervention group
Group type: COMPARATOR
Intervention: 2.94 g protein/kg body cell mass/d (adequate diet)
Number of subjects: 12
Study 8707238 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.125 mg brotizolam
Number of subjects: 49
Study 8707238 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.250 mg brotizolam
Number of subjects: 49
Study 8707238 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 49
Study 1521686 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct evaluation using USPHS method
Number of subjects: 202
Study 1521686 — intervention group
Group type: EXPERIMENTAL
Intervention: Indirect evaluation using M‐L scale
Number of subjects: 202
Study 1521686 — intervention group
Group type: EXPERIMENTAL
Intervention: USPHS evaluation system category of anatomic form
Number of subjects: 202
Study 31772100 — intervention group
Group type: EXPERIMENTAL
Intervention: Outpatient care (discharge on the day of surgery, within 6-8 hours)
Number of subjects: 104
Study 31772100 — intervention group
Group type: COMPARATOR
Intervention: Inpatient care (hospital stay for 1-3 nights after surgery)
Number of subjects: 104
Study 31772100 — intervention group
Group type: EXPERIMENTAL
Intervention: Outpatient care
Number of subjects: 104
Study 28439987 — intervention group
Group type: EXPERIMENTAL
Intervention: Silodosin 8 mg/day
Number of subjects: 0
Study 28439987 — intervention group
Group type: COMPARATOR
Intervention: Tadalafil 5 mg/day
Number of subjects: 0
Study 28439987 — intervention group
Group type: EXPERIMENTAL
Intervention: Silodosin (after switching from Tadalafil)
Number of subjects: 0
Study 25546001 — intervention group
Group type: EXPERIMENTAL
Intervention: Tafamidis 400 mg
Number of subjects: 42